Innocenti 1977.

Study characteristics
Methods	Trial design: randomised, double‐blind, within‐participant study Trial registration number: not reported Country: Italy, assumed by the authors' affiliation Outpatient or hospital: Sondrio Civil Hospital Dermatology Department, assumed by the authors' affiliation Date trial conducted: not reported Duration of trial participation: 1 week Inclusion criteria: patients with bilateral AD where the lesions were distributed symmetrically Exclusion criteria: patients without complete clinical assessment Additional design details: AD participants were a subgroup in the study.
Participants	Total number randomised: 3 participants with AD sides treated (3 sides to apply the intervention and 3 sides to apply the comparator) Age, sex: not reported separately for the AD participants Ethnicity, duration of eczema: not reported Severity of eczema: 2 participants had moderate‐severity disease and 1 had high‐severity Body site, number of withdrawals: not reported Notes: none
Interventions	Run‐in details: not reported Intervention: diflucortolone valerate 0.1% emulsion used twice daily for 7 days · Concurrent treatment: not reported · Other key information: potency inferred based on alternative formulations Comparator: fluocortolone/fluocortolone caproate 0.25% emulsion used twice daily for 7 days · Concurrent treatment: not reported · Other key information: potency inferred based on alternative formulations Concurrent treatments received alongside both intervention and comparator: not reported Notes: none
Outcomes	· AE · IGA (treatment effect judged as null, small, good, or excellent)
Notes	Funding source: not reported Declarations of interest: not declared Original language of publication: Italian Other: This study has previously been extracted by this group; some content is reproduced from Lax 2022.